The blood option: transcriptional profiling in clinical trials

Pharmacogenomics
Alison E Baird

Abstract

Transcriptional profiling of peripheral blood shows considerable promise, with the number of clinical studies increasing rapidly over the past 2-3 years. Peripheral blood is in contact with almost every tissue of the body, is the most readily accessible source of RNA in the clinical setting, and allows for repeated measurements. Studies have already been performed across multiple clinical disciplines and before and after therapeutic intervention. However, blood transcriptional profiling is not yet ready to be applied in clinical practice. A number of methodological issues and hurdles need to be overcome, with issues of standardizing blood sample collection and processing of paramount importance. The specificity of gene expression signatures for individual disease states also needs to be established. Large-scale, well-planned and integrated approaches across multiple medical disciplines could accelerate the pace of research, by resolving these methodological issues and by determining the clinical applications of blood transcriptional profiling, particularly in relation to clinical trials.

References

Dec 1, 1996·Nature Biotechnology·D J LockhartE L Brown
Jan 23, 1999·Nature Genetics·E S Lander
Nov 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A BhattacharjeeM Meyerson
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Carl VirtanenMichael H Jones
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Feb 19, 2004·Nature Reviews. Genetics·UNKNOWN Tumor Analysis Best Practices Working Group
Mar 26, 2004·Nature·Olli Kallioniemi
Apr 16, 2004·The New England Journal of Medicine·Edison T Liu, Krishna R Karuturi
Nov 19, 2004·Physiological Genomics·Robert J FeezorUNKNOWN Inflammation and Host Response to Injury, Large-Scale Collaborative Research Program
Feb 12, 2005·Lancet·John P A Ioannidis
Mar 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·J Perren CobbUNKNOWN Inflammation and Host Response to Injury Large-Scale Collaborative Research Program
Apr 23, 2005·Nature Methods·Gavin Sherlock
Apr 23, 2005·Nature Methods·Jennie E LarkinJohn Quackenbush
Apr 23, 2005·Nature Methods·Rafael A IrizarryWayne Yu
Apr 23, 2005·Nature Methods·Theodore BammlerUNKNOWN Members of the Toxicogenomics Research Consortium
Mar 7, 2006·Pharmacogenomics·Michael E Burczynski, Andrew J Dorner

❮ Previous
Next ❯

Citations

Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jose de Leon
Oct 1, 2007·Expert Opinion on Medical Diagnostics·Enrico Domenici, Pierandrea Muglia
May 20, 2015·The Journal of Molecular Diagnostics : JMD·Sanja VickovicJoakim Lundeberg
Oct 25, 2013·International Review of Psychiatry·Andreas Menke
Feb 25, 2014·Drug Discovery Today·Barbara BreitensteinFlorian Holsboer
Nov 30, 2010·Biological Research for Nursing·Taura L BarrYvette Conley
Jan 31, 2007·Stroke; a Journal of Cerebral Circulation·Alison E Baird
Nov 1, 2006·Biochemical Society Transactions·A E Baird

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.